课题基金 / 基金详情

Interaction between endogeneous mutator AID and exogenous oncogenic factors in carcinogenesis

Interaction between endogeneous mutator AID and exogenous oncogenic factors in carcinogenesis
内源性突变 AID 与外源性致癌因子在致癌过程中的相互作用
批准号:
18390122
负责人:
KINOSHITA Kazuo
金额:
$10.77万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

KINOSHITA Kazuo的其他基金

相似基金

相关文献

中文摘要
翻译
激活诱导型胞苷脱氨酶(AID)是一种独特的能在基因组中诱导突变的酶,是免疫球蛋白基因的体细胞超突变和类切换重组的重要因子。本研究表明,AID不仅在活化的B淋巴细胞中表达,而且在慢性肝炎的肝脏和肝细胞癌组织中也有表达。丙型肝炎病毒感染可上调肝细胞中的辅助性蛋白表达。在胃中,幽门螺杆菌感染可诱导胃上皮细胞AID表达。在胃癌细胞系中表达的AID可以诱导肿瘤抑制基因P53的点突变。这些发现共同提示AID参与了慢性炎症和感染背景下发生的上皮性癌的发病机制。为了阐明AID在癌症中的作用,我们在小鼠身上进行了化学致癌实验。最初,我们使用了带有普遍存在的结构性启动子的AID转基因小鼠,但由于致死性淋巴瘤的频繁和早期死亡,这些启动子被证明不适合进行定量研究。第二项试验使用缺乏淋巴细胞的小鼠,由于频繁肺炎导致生长迟缓而失败。因此,我们开始了第三个试验,利用皮肤特异性角蛋白14启动子产生了一种新的AID转基因小鼠系。将获得的小鼠回交到易发生皮肤肿瘤的FVB/N品系。由化学物质诱导的皮肤肿瘤才刚刚开始。
英文摘要
Activation-induced cytidine deaminase(AID) is a unique enzyme that can induce mutations in the genome and is an essential factor for somatic hypermutation and class-switch recombination of the immunoglobulin genes. This study revealed that AID was expressed not only in activated B lymphocytes but also in the liver under chronic hepatitis and tissues of hepatocellular carcinoma. AID expression in hepatocytes was upregulated by infection with hepatitis C virus. In the stomach, AID expression was induced in the epithelium by infection with Helicobacter pylori. AID expressed in a gastric cancer cell line could induce point mutations in a tumor suppressor p53 gene. These findings collectively suggested involvement of AID in the pathogenesis of epithelial cancer arising in the background of chronic inflammation and infection. To clarify role of AID in cancer, experiments of chemical-induced carcinogenesis were performed in mice. Initially, we used AID transgenic mice with ubiquitous and constitutive promoter, which were turned out to be unsuitable for the quantitative study because of frequent and early death from lethal lymphoma. The second trial using mice that lack lymphocytes failed due to growth retardation by frequent pneumonia. Therefore, we started the third trial generating a novel line of AID transgenic mice using skin-specific keratin 14 promoter. Obtained mice were backcrossed to FVB/N strain, which is prone to develop skin tumor. The skin tumor induction by chemicals has just begun.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/ijc.22292
发表时间: 2007-02-01
期刊: INTERNATIONAL JOURNAL OF CANCER
影响因子: 6.4
作者: [Kou, Tadayuki, Marusawa, Hiroyuki, Chiba, Tsutomu]
通讯作者: Chiba, Tsutomu
Hepatitis C virus triggers aberrant expression of actovaton-induced cytidine deaminase (AID) in human hepatocytes
丙型肝炎病毒触发人肝细胞中 Actovaton 诱导的胞苷脱氨酶 (AID) 的异常表达
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [遠藤容子, 他]
通讯作者: 他
Identification of a specific domain required for dimerization of activation-induced cytidine deaminase
活化诱导胞苷脱氨酶二聚化所需的特定结构域的鉴定
DOI: --
发表时间: 2006
期刊: J. Biol. Chem. 281・28
影响因子: --
作者: [Wang, J. et al.]
通讯作者: J. et al.
「研究成果報告書概要(和文)」より
摘自《研究结果报告摘要(日文)》
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Kawauchi, et. al., Nishimura et al., Dezawa et al., Yoshizawa et al., 星野 幹雄, 星野 幹雄]
通讯作者: 星野 幹雄
共 13 条
    Mechanisms of diseases by chromosomal translocation
    • 批准号:
      20590326
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      KINOSHITA Kazuo
    • 依托单位:
    Carcinogenesis by a genome mutator AID
    • 批准号:
      17013042
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $31.04万
    • 财政年份:
      2005
    • 负责人:
      KINOSHITA Kazuo
    • 依托单位:
    Interaction between endogenous mutator AID and exogenous oncogenic factors in carcinogenesis
    • 批准号:
      16390115
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2004
    • 负责人:
      KINOSHITA Kazuo
    • 依托单位:
    国内基金
    海外基金
    5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
    • 批准号:
      82372743
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      陈卓佳
    • 依托单位:
    脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
    • 批准号:
      82371223
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      闻大翔
    • 依托单位:
    丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
    • 批准号:
      82373139
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      李孟鸿
    • 依托单位:
    均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
    • 批准号:
      82372089
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      李万万
    • 依托单位: